Literature DB >> 34448913

Coombs' test positive autoimmune hemolytic anemia accompanied by myelodysplastic syndrome that became Coombs' test negative after azacitidine administration.

Shinya Yamada1, Sayaka Kajikawa2, Noriharu Nakagawa2, Yukio Kondo2, Hirokazu Okumura2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34448913     DOI： 10.1007/s00277-021-04652-3

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  9 in total

1.  Autoimmune hemolytic anemia occurring with myelodysplastic syndrome: report of a pediatric case and review of the literature.

Authors:  H Oren; C Uçar; H Gülen; M Duman; G Irken
Journal:  Ann Hematol       Date:  2001-09       Impact factor: 3.673

2.  Myelodysplastic syndrome complicated by autoimmune hemolytic anemia: remission of refractory anemia following mycophenolate mofetil.

Authors:  J-T Lin; W-S Wang; C-C Yen; T-J Chiou; J-H Liu; L-T Hsiao; M-H Yang; T-C Chao; C-J Tai; P-M Chen
Journal:  Ann Hematol       Date:  2002-11-16       Impact factor: 3.673

3.  The autoimmune manifestations associated with myelodysplastic syndrome respond to 5-azacytidine: a report on three cases.

Authors:  Sylvain Pilorge; Luc Moulonguet Doleris; François Dreyfus; Sophie Park
Journal:  Br J Haematol       Date:  2011-01-31       Impact factor: 6.998

4.  Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.

Authors:  Bruce D Cheson; Peter L Greenberg; John M Bennett; Bob Lowenberg; Pierre W Wijermans; Stephen D Nimer; Antonio Pinto; Miloslav Beran; Theo M de Witte; Richard M Stone; Moshe Mittelman; Guillermo F Sanz; Steven D Gore; Charles A Schiffer; Hagop Kantarjian
Journal:  Blood       Date:  2006-04-11       Impact factor: 22.113

5.  Function and X chromosome inactivation analysis of B lymphocytes in myelodysplastic syndromes with immunological abnormalities.

Authors:  M Okada; T Okamoto; Y Takemoto; A Kanamaru; E Kakishita
Journal:  Acta Haematol       Date:  2000       Impact factor: 2.195

6.  Sustained erythrocytosis due to the use of Lenvatinib.

Authors:  Jaspreet Kaur; Shahaf Tuler; Constantin A Dasanu
Journal:  J Oncol Pharm Pract       Date:  2021-10-19       Impact factor: 1.809

Review 7.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

Review 8.  Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting.

Authors:  Ulrich Jäger; Wilma Barcellini; Catherine M Broome; Morie A Gertz; Anita Hill; Quentin A Hill; Bernd Jilma; David J Kuter; Marc Michel; Marco Montillo; Alexander Röth; Sacha S Zeerleder; Sigbjørn Berentsen
Journal:  Blood Rev       Date:  2019-12-05       Impact factor: 8.250

9.  Successful treatment by azacitidine therapy of intestinal Behçet's disease associated with myelodysplastic syndrome.

Authors:  Hiroaki Tanaka; Naomi Shimizu; Emi Tougasaki; Chika Kawajiri; Shinichiro Hashimoto; Yusuke Takeda; Shio Sakai; Masahiro Takeuchi; Chikako Ohwada; Emiko Sakaida; Toshiyuki Takagi; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2013-03-22       Impact factor: 2.490
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.